Is Sensei Biotherapeutics Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: SNSE) stock is to Strong Buy SNSE stock.
Out of 2 analysts, 1 (50%) are recommending SNSE as a Strong Buy, 1 (50%) are recommending SNSE as a Buy, 0 (0%) are recommending SNSE as a Hold, 0 (0%) are recommending SNSE as a Sell, and 0 (0%) are recommending SNSE as a Strong Sell.
What is SNSE's forecast return on equity (ROE) for 2024-2027?
(NASDAQ: SNSE) forecast ROE is N/A, which is considered weak.
What is SNSE's Price Target?
According to 2 Wall Street analysts that have issued a 1 year SNSE price target, the average SNSE price target is $4.50, with the highest SNSE stock price forecast at $5.00 and the lowest SNSE stock price forecast at $4.00.
On average, Wall Street analysts predict that Sensei Biotherapeutics's share price could reach $4.50 by May 14, 2025. The average Sensei Biotherapeutics stock price prediction forecasts a potential upside of 194.12% from the current SNSE share price of $1.53.
What is SNSE's forecast return on assets (ROA) for 2024-2027?
(NASDAQ: SNSE) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.